Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
This does not mean these items must be avoided entirely, but many patients report needing smaller portions or slower eating paces to stay comfortable
Wegovy (semaglutide) is a GLP-1 receptor agonist that helps reduce hunger and appetite, allowing you to eat fewer calories, lose weight, and manage your blood sugar levels
Use our semaglutide dosage calculator as a starting reference
If you're already taking one, speak to your prescriber about switching rather than combining
Given the rapid increase in semaglutide use and its possible licensing for a range of problems other than obesity and type 2 diabetes, this issue deserves further study, but possible drug side-effects always need to be balanced against likely benefits. Semaglutide under the brand name Wegovy has been prescribed for weight loss on the NHS since 2023
US$ 20.36
US$ 29.56
US$ 29.04
US$ 28.55
US$ 24.00
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 28.65
